Rival Stapler Maker Sues Medtronic Over Contracts
Hospital buyers and surgical device competitors face scrutiny of multi-product contracts that may limit rival products.
Updated on Nov. 6, 2026 in Healthcare

Lexington Medical, a Massachusetts maker of laparoscopic universal handle staplers, filed a 63-page federal antitrust lawsuit against Medtronic in Boston. The suit alleges Medtronic's restrictive hospital contracts keep rival staplers out of the market, affecting surgical device buyers and competing manufacturers.
Why it matters
Lexington says its AEON stapler is superior but cannot compete because Medtronic holds more than 90% of the laparoscopic stapler market and uses restrictive agreements with hospitals. The filing follows a separate Applied Medical Resources case in which Medtronic was ordered to pay $382 million, signaling that bundling and exclusivity practices in medical devices face growing legal scrutiny.
The complaint cites Medtronic's more than 90% share of the laparoscopic stapler market, and Lexington reports its AEON system was rated clinically superior to Medtronic's product in 89% of trial cases. The separate Applied Medical judgment against Medtronic totals $382 million, which the complaint treats as context for the pattern of alleged exclusionary conduct.
The players
Lexington Medical
A Massachusetts-based maker of laparoscopic universal handle staplers, including the AEON Endoscopic Stapling System, competing against Medtronic in hospital surgical supply.
Medtronic
A Minnesota-based global medical device maker holding more than 90% of the laparoscopic stapler market, whose hospital contracting practices are now under antitrust challenge.
Applied Medical Resources Corp.
A surgical device manufacturer that won a jury verdict against Medtronic over alleged unlawful bundling of its LigaSure device, resulting in $382 million in damages.
The details
Lexington alleges Medtronic tries to stop hospitals from running trials of rival products and ties discounts, rebates and pricing tiers to purchases spanning multiple product categories. Because a hospital's savings depend on buying across Medtronic's broader lineup, a competing stapler can be effectively shut out even when it performs better. Medtronic's CEO, Geoff Martha, said in 2025 that the company has 'very tight contracts,' a statement now part of the broader dispute.
Timeline
2010: CareFusion filed a lawsuit claiming Medtronic was unlawfully killing competition.
2025: Medtronic CEO Geoff Martha said the company has 'very tight contracts.'
Earlier in 2026: A jury ruled against Medtronic in the Applied Medical Resources case over its LigaSure device bundling.
November 5, 2026: Lexington Medical filed its antitrust lawsuit against Medtronic in Boston.
Market Landscape
The Lexington complaint follows the Applied Medical verdict, which found Medtronic unlawfully bundled its LigaSure device with other products. Lexington's claim extends that theory to laparoscopic staplers, where Medtronic already holds more than 90% share.
Hospital purchasing teams should review how volume-based discounts and multi-category rebate tiers interact with the standardization of surgical staplers. Device makers outside the market leader should track whether antitrust scrutiny of exclusive contracting reshapes how hospitals evaluate competing products.
The takeaway
Operators in healthcare purchasing should examine whether their supply contracts tie pricing to purchases across unrelated product lines, since that structure is now at the center of two antitrust cases. Monitor the Boston docket for early rulings on the Lexington complaint as an indicator of how courts will treat similar hospital contracting practices.
Further reading
Follow more coverage of the medical device industry in our Healthcare section.
Source note: This article includes information reported by Court House News Service.




